Nickel Molybdenum Hard Chrome Alternative

Source: sbir.gov Agency: DOD Branch: USAF Program: SBIR Phase I Topic: DAF26BZ03-DV021 Research Area: The "Nickel Molybdenum Hard Chrome Alternative" topic under AFWERX aims to advance an innovative solution for replacing hexavalent chromium use in aerospace applications, such as landing gear actuators. Hexavalent chromium is known for its adverse health and environmental impacts, and the Department of War (DoW) faces regulatory mandates to eliminate its usage. The U.S. Army is tasked with phasing out hexavalent chromium by 2030, and similar efforts are underway in Navy facilities with a target Status: open Requirements: The "Nickel Molybdenum Hard Chrome Alternative" topic under AFWERX aims to advance an innovative solution for replacing hexavalent chromium use in aerospace applications, such as landing gear actuators. Hexavalent chromium is known for its adverse health and environmental impacts, and the Department

Eligibility

Small businesses (< 500 employees), US-owned

small_business

Similar opportunities

grant

SBA

SBIR/STTR Commercialization Readiness Pilot (SB1)

Source: sbir.gov Agency: SBA Branch: SBA Program: SBIR Phase CRP Topic: SB1-2026 Research Area: Commercialization / Technology Transfer / Innovation Status: new Requirements: Commercialization Readiness Pilot program to help SBIR/STTR awardees transition technologies to market.

$2,153,927Apr 6, 2027

grant

NIH

NIH SBIR Phase IIB Strategic Breakthrough Award [R44]

Source: sbir.gov Agency: HHS Branch: NIH Program: SBIR Phase IIB Topic: PA-26-SBIR-R44-IIB Research Area: Health Technology / Biotech / Commercialization / Strategic Breakthrough Status: new Requirements: Phase IIB Strategic Breakthrough Award for SBIR companies with demonstrated Phase II results seeking additional commercialization funding.

$2,153,927Apr 6, 2027

grant

NIH

NIH STTR [R41/R42] – Clinical Trial Optional

Source: sbir.gov Agency: HHS Branch: NIH Program: STTR Phase I/II Topic: PA-26-STTR-R41R42 Research Area: Health Technology / Biotech / Clinical Research / University Partnerships Status: new Requirements: Parent STTR omnibus solicitation for NIH. Clinical trial optional. Requires small business-research institution partnership.

$2,153,927Apr 6, 2027

grant

NIH

NIH, CDC and FDA SBIR [R43/R44] – Clinical Trial Optional

Source: sbir.gov Agency: HHS Branch: NIH Program: SBIR Phase I/II Topic: PA-26-SBIR-R43R44 Research Area: Health Technology / Biotech / Clinical Research / Public Health Status: new Requirements: Parent SBIR omnibus solicitation for NIH, CDC, and FDA. Clinical trial optional. Covers broad health technology and biomedical research areas.

$2,153,927Apr 6, 2027